Business & Tech Elizabeth Holmes's Lawyers Make End Run To Have Fraud Case Thrown Out An attorney for Holmes moved to have a federal judge throw out all 11 fraud charges against the two defendants claiming the government's case is too "broad" and "full of ambiguity and fudging language."
SF News Feds Finding Ways to Bleed Accused Fraudster Elizabeth Holmes of $700 Million (If Found Guilty) It’s real deep legal trouble for the fake deep-voiced Theranos founder, who could be on the hook for more than a half-billion dollars.
SF News Elizabeth Holmes Spotted Looking 'Happy' In The Marina, Recognized By Her Voice Disgraced local biotech whiz kid and accused fraudster Elizabeth Holmes came throatily back into the news with that HBO doc, and now Inside Edition is chasing her around SF.
SF News Theranos Offers More Shares To Investors Who Pinky Swear Not To Sue Riddle me this: You think you might want to sue a company. But instead, would you like a lot of shares in it? If you like the sound of that deal, you'll love
SF News Theranos Whistleblower Was Grandson Of Board Member George Shultz, Former Secretary Of State The walls are closing in around Palo Alto-based "blood testing" startup Theranos, whom erstwhile partner Walgreens is now suing for $140 million in voided tests. But a new layer to the drama has
SF News Walgreens Is Suing Theranos For $140 Million Over Voided Blood Tests Walgreens is suing the embattled health startup Theranos over claims that the company breached its contract with the pharmacy chain after it was forced to void years worth of blood tests and give
SF News Theranos Deathwatch: First Major Investor Sues Company For 'Series Of Lies' The walls continue to close in around Theranos and it's founder Elizbaeth Holmes as the first — and probably not the last — of a group of major investors who pumped a cumulative $800 million
SF News Theranos To Lay Off Hundreds And Give Up Blood Testing Following Regulatory Clampdown Elizabeth Holmes, the embattled CEO of blood testing company Theranos announced last night in a letter to company stakeholders that the startup she founded will abandon its core mission and will no longer
SF News Theranos Deathwatch: Feds Ban Elizabeth Holmes From Running Blood Lab For 2 Years In the final episode of this past season of the HBO show Silicon Valley, a character seeking to justify questionable business practices puts it this way: His core product is solid, if some
Arts & Entertainment Jennifer Lawrence To Play Disgraced Theranos CEO Elizabeth Holmes In Upcoming Film In yet another example of Hollywood being obsessed with Silicon Valley lately, a new film is in the works by director/screenwriter Adam McKay (The Big Short, Anchorman) telling the story of the
SF News Forbes: Theranos CEO Elizabeth Holmes Net Worth Now Zero Dollars Elizabeth Holmes, the CEO of blood testing startup Theranos, has had a rough year. News broke in April that the company, which she founded, was under criminal investigation and an SEC probe for
SF News Blood Testing Startup Theranos Is Now Under Criminal Investigation, SEC Probe Federal prosecutors are investigating the possibility that Theranos, Inc., a blood testing startup once valued at $9 billion, misled its investors with regard to its proprietary pin-prick blood sample technology. That was the
SF News CEO Of Healthcare Startup Theranos Faces 2-Year Ban From Blood Testing Biz Theranos founder and chief executive Elizabeth Holmes, a 32-year-old Stanford dropout who claims her aversion to needles led her to invent proprietary blood testing technology requiring just a pin-prick, faces a two-year ban
SF News Labs For Healthcare Startup Theranos Present 'Immediate Jeopardy To Patient Safety' The first results from an investigation into Palo Alto-based healthcare technology startup Theranos are in, and they aren't favorable for the health of the formerly whinnying Silicon Valley Unicorn. The blood-sampling technology upon
SF News Health Regulators Investigating Complaints Against Healthcare Startup Theranos From Former Employees Palo Alto-based healthcare technology startup Theranos has been on the defensive since its core blood-sampling technology's capabilities were called into question by a Wall Street Journal article in October. Headed by founder and
